Hainan Shuangcheng Pharmaceuticals Co., Ltd. elected Bai Jing as non-independent director of the company, at its first extraordinary general meeting of 2022 held on 26 January 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.28 CNY | -5.93% |
|
-6.55% | -43.01% |
22/05 | Workshop of Shuangcheng Pharma's Unit Passes Regulatory Inspection; Shares Up 3% | MT |
07/05 | Shuangcheng Pharma Gets FDA Nod to Market Acromegaly Drug in US | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.01% | 25Cr | |
+20.60% | 4.33TCr | |
+27.64% | 2.24TCr | |
+19.96% | 1.55TCr | |
+19.14% | 1.45TCr | |
+55.11% | 1.29TCr | |
-0.05% | 678.76Cr | |
-11.39% | 655.78Cr | |
+17.73% | 587.1Cr | |
-8.87% | 572.55Cr |
- Stock Market
- Equities
- 002693 Stock
- News Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- Hainan Shuangcheng Pharmaceuticals Co., Ltd. Elects Bai Jing as Non-Independent Director